Risk assessment for sudden cardiac death in dialysis patients

Circulation: Arrhythmia and Electrophysiology

Volumn 3, Issue 5, 2010, Pages 553-559

  Saravanan, Palaniappan ^a,b   Davidson, Neil C ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Death sudden cardiac; Dialysis; Kidney failure chronic; Risk assessment

Indexed keywords

PHENYLEPHRINE;

ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DISEASE PREDISPOSITION; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE TACHYCARDIA; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HOLTER MONITORING; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; INCIDENCE; KIDNEY FAILURE; PATIENT IDENTIFICATION; PRESSORECEPTOR; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; QT INTERVAL; RISK ASSESSMENT; SUDDEN DEATH; UREMIA; CHRONIC KIDNEY FAILURE; METHODOLOGY; MORTALITY; PROGNOSIS; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SURVIVAL RATE;

DEATH, SUDDEN, CARDIAC; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 78049514712     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.110.937888     Document Type: Article

References (54)

1. United States Renal Data System, 2008 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2009.
2. Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients. Semin Dial. 2008;21:300-307.
3. Genovesi S, Valsecchi MG, Rossi E, Pogliani D, Acquistapace I, De Cristofaro V, Stella A, Vincenti A. Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant. 2009;24:2529-2536.
4. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D, Levey AS; HEMO Study Group. Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO study. Kidney Int. 2004;65:2380-2389. (Pubitemid 38670024)
5. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E; German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238-248. (Pubitemid 41058323)
6. Herzog CA, Strief JW, Collins AJ, Gilbertson DT. Cause-specific mortality of dialysis patients after coronary revascularization: Why don't dialysis patients have better survival after coronary intervention? Nephrol Dial Transplant. 2008;23:2629-2633.
7. Krishnan AV, Kiernan MC. Uremic neuropathy: Clinical features and new pathophysiological insights. Muscle Nerve. 2007;35:273-290. (Pubitemid 46364083)
8. Parfrey PS, Foley RN, Harnett JD. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996; 11:1277-1285. (Pubitemid 26241416)
9. Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, Steedman T, Dargie HJ, Jardine AG. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int. 2006;69:1839-1845. (Pubitemid 43739213)
10. Tun A, Khan IA, Wattanasauwan N, Win MT, Hussain A, Hla TA, Cherukuri VL, Vasavada BC, Sacchi TJ. Increased regional and transmyocardial dispersion of ventricular repolarization in end-stage renal disease. Can J Cardiol. 1999;15:53-56. (Pubitemid 29080517)
11. Yetkin E, Ileri M, Tandoǧan I, Boran M, Yanik A, Hisar I, Kutlu M, Cehreli S, Korkmaz S, Göksel S. Increased QT interval dispersion after hemodialysis: Role of peridialytic electrolyte gradients. Angiology. 2000; 51:499-504. (Pubitemid 30415815)
12. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp- Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. (Pubitemid 40110811)
13. Goldenberg I, Moss AJ. Implantable cardioverter defibrillator efficacy and chronic kidney disease: Competing risks of arrhythmic and nonarrhythmic mortality. J Cardiovasc Electrophysiol. 2008;19:1281-1283.
14. Mangrum JM, Lin D, Dimarco JP, Lake DE, Bolton WK, Mangrum AJ. Prognostic value of left ventricular systolic function in renal dialysis patients. Heart Rhythm. 2006;3:S154.
15. Saravanan P, Freeman G, Davidson NC. Risk assessment for sudden cardiac death in dialysis patients: How relevant are conventional cardiac risk factors? Int J Cardiol. 2009. doi:10.1016/ j.ijcard. 2009.03.048.
16. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: Executive summary. Heart Rhythm. 2008;5:934-955.
17. Sakhuja R, Keebler M, Lai TS, McLaughlin Gavin C, Thakur R, Bhatt DL. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol. 2009;103:735-741.
18. Amin MS, Fox AD, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA. Benefit of primary prevention implantable cardioverter defibrillators in the setting of chronic kidney disease: A decision model analysis. J Cardiovasc Electrophysiol. 2008;19:1275-1280.
19. Cuculich PS, Sánchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol. 2007;30: 207-213. (Pubitemid 46333676)
20. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 2005;68:818-825. (Pubitemid 43323139)
21. Morris ST, Galiatsou E, Stewart GA, Rodger RS, Jardine AG. QT dispersion before and after hemodialysis. J Am Soc Nephrol. 1999;10: 160-163. (Pubitemid 29034955)
22. Wu VC, Lin LY, Wu KD. QT interval dispersion in dialysis patients. Nephrology (Carlton). 2005;10:109-112.
23. Stewart GA, Gansevoort RT, Mark PB, Rooney E, McDonagh TA, Dargie HJ, Stuart R, Rodger C, Jardine AG. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int. 2005;67:217-226. (Pubitemid 40019243)
24. Krane V, Heinrich F, Meesmann M, Olschewski M, Lilienthal J, Angermann C, Störk S, Bauersachs J, Wanner C, Frantz S; German Diabetes and Dialysis Study Investigators. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol. 2009;4:394-400.
25. Tin LL, Beevers DG, Lip GY. Hypertension, left ventricular hypertrophy, and sudden death. Curr Cardiol Rep. 2002;4:449-457.
26. Amann K, Rychlík I, Miltenberger-Milteny G, Ritz E. Left ventricular hypertrophy in renal failure. Kidney Int. 1998;68(suppl):S78-S85. (Pubitemid 28531781)
27. Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, Cannella G. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: A 10 year survey. Nephrol Dial Transplant. 2004;19:1829-1834. (Pubitemid 38961395)
28. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol. 2001;12:2759-2767. (Pubitemid 33115424)
29. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation. 1998;98: 2334-2351. (Pubitemid 28533855)
30. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad- Tarazi F, Victor RG. Sympathetic over activity in patients with chronic renal failure. N Engl J Med. 1992;327:1912-1918. (Pubitemid 23006966)
31. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS. Plasma norepinephrine predicts survival and incident cardio- vascular events in patients with end-stage renal disease. Circulation. 2002; 105:1354-1359. (Pubitemid 34260428)
32. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043-1065.
33. Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: Measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005;10:88-101. (Pubitemid 40476672)
34. Hayano J, Takahashi H, Toriyama T, Mukai S, Okada A, Sakata S, Yamada A, Ohte N, Kawahara H. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant. 1999;14:1480-1488. (Pubitemid 29241742)
35. Fukuta H, Hayano J, Ishihara S, Sakata S, Mukai S, Ohte N, Ojika K, Yagi K, Matsumoto H, Sohmiya S, Kimura G. Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant. 2003;18:318-325. (Pubitemid 36181683)
36. Oikawa K, Ishihara R, Maeda T, Yamaguchi K, Koike A, Kawaguchi H, Tabata Y, Murotani N, Itoh H. Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol. 2009;131: 370-377.
37. Nishimura M, Tokoro T, Nishida M, Hashimoto T, Kobayashi H, Yamazaki S, Imai R, Okino K, Iwamoto N, Takahashi H, Ono T. Sympathetic over activity and sudden cardiac death among hemodialysis patients with left ventricular hypertrophy. Int J Cardiol. 2010;142:80-86.
38. Windhagen-Mahnert B, Kadish AH. Application of non-invasive and invasive tests for risk assessment in patients with ventricular arrhythmias. Cardiol Clin. 2000;18:243-263. (Pubitemid 30331647)
39. Johansson M, Gao SA, Friberg P, Annerstedt M, Bergström G, Carlström J, Ivarsson T, Jensen G, Ljungman S, Mathillas O, Nielsen FD, Strömbom U. Reduced baroreflex effectiveness index in hypertensive patients with chronic renal failure. Am J Hypertens. 2005;18:995-1000. (Pubitemid 41040272)
40. Johansson M, Gao SA, Friberg P, Annerstedt M, Carlström J, Ivarsson T, Jensen G, Ljungman S, Mathillas O, Nielsen FD, Strömbom U. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. J Hypertens. 2007;25:163-168. (Pubitemid 44885678)
41. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson WG, Zipes DP; American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol. 2008;52:1179-1199.
42. Ikeda T, Yoshino H, Sugi K, Tanno K, Shimizu H, Watanabe J, Kasamaki Y, Yoshida A, Kato T. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: Results of a collaborative cohort study. J Am Coll Cardiol. 2006;48:2268-2274. (Pubitemid 44855424)
43. Stein PK, Sanghavi D, Domitrovich PP, Mackey RA, Deedwania P. Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study. J Cardiovasc Electrophysiol. 2008;19:1037-1042.
44. Friedman AN, Groh WJ, Das M. A pilot study in hemodialysis of an electrophysiological tool to measure sudden cardiac death risk. Clin Nephrol. 2007;68:159-164. (Pubitemid 47377338)
45. Morales MA, Gremigni C, Dattolo P, Piacenti M, Cerrai T, Fazi A, Pelosi G, Vergassola R, Maggiore Q. Signal-averaged ECG abnormalities in haemodialysis patients: Role of dialysis. Nephrol Dial Transplant. 1998; 13:668-673. (Pubitemid 28119050)
46. Ichikawa H, Nagake Y, Makino H. Signal averaged electrocardiography (SAECG) in patients on hemodialysis. J Med. 1997;28:229-243. (Pubitemid 27464920)
47. Girgis I, Contreras G, Chakko S, Perez G, McLoughlin J, Lafferty J, Gualberti L, Ammazzalorso M, Constantino T, Bresznyak ML, Kleiner M, McGinn TG, Myerburg RJ. Effect of hemodialysis on the signalaveraged electrocardiogram. Am J Kidney Dis. 1999;34:1105-1113.
48. Meier P, Vogt P, Blanc E. Ventricular arrhythmias and sudden cardiac death in end-stage renal disease patients on chronic hemodialysis. Nephron. 2001;87:199-214. (Pubitemid 32268561)
49. Mohi-ud-din K, Bali HK, Banerjee S, Sakhuja V, Jha V. Silent myocardial ischemia and high-grade ventricular arrhythmias in patients on maintenance hemodialysis. Ren Fail. 2005;27:171-175. (Pubitemid 40393128)
50. Burton JO, Korsheed S, Grundy BJ, McIntyre CW. Hemodialysisinduced left ventricular dysfunction is associated with an increase in ventricular arrhythmias. Ren Fail. 2008;30:701-709.
51. Perl J, Chan CT. Timing of sudden death relative to the hemodialysis procedure. Nat Clin Pract Nephrol. 2006;2:668-669. (Pubitemid 44862700)
52. Voroneanu L, Covic A. Arrhythmias in hemodialysis patients. J Nephrol. 2009;22:716-725.
53. Farrell TG, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED, Ward DE, Camm AJ. Risk stratification for arrhythmic events in post-infarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1991;18:687-697.
54. Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, Guzik P, Lombardi F, Müller A, Oto A, Schneider R, Watanabe M, Wichterle D, Zareba W. Heart rate turbulence: Standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Non-invasive Electrophysiology Consensus. J Am Coll Cardiol. 2008;52:1353-1365.